Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jang Ho Cho

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Cancer Research and Treatment|June 20, 2018
EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent ChemoradiotherapySong Ee Park, Jae Myoung Noh, You Jin Kim, et al.
Cancer Investigation|February 6, 2026
Predictive and Prognostic Value of p16 in Head and Neck Squamous Cell Carcinoma Patients Treated with Molecular Targeted Agents or Immune Checkpoint Inhibitors: Subgroup Analysis of the TRIUMPH StudyHyerim Ha, Sang Hoon Chun, Yun-Gyoo Lee, et al.
Cancers|July 9, 2020
Prognostic Value of <i>CD200R1</i> mRNA Expression in Head and Neck Squamous Cell CarcinomaHyun Chang, Yun-Gyoo Lee, Yoon Ho Ko, et al.
JTO Clinical and Research Reports|December 2, 2024
Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18Dae-Ho Choi, Miso Kim, Young Saing Kim, et al.
BMC Cancer|February 23, 2024
Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06)Sung Hee Lim, Keun-Wook Lee, Jae-Joon Kim, et al.
Translational Lung Cancer Research|April 15, 2026
Molecular and clinical disparity of <i>EGFR</i>-mutant non-small cell lung cancer (NSCLC) based on histopathological stage and <i>EGFR</i> molecular subtypesDayoung Yoon, Ji Won Lee, Byoung Chul Cho, et al.
Cancer Research and Treatment|May 21, 2021
Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic AlterationsYoon Ji Choi, Jung Yoon Choi, Ju Won Kim, et al.
Journal of Gastric Cancer|January 17, 2025
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline)In-Ho Kim, Seung Joo Kang, Wonyoung Choi, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Cancer Research and Treatment|June 20, 2018
EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent ChemoradiotherapySong Ee Park, Jae Myoung Noh, You Jin Kim, et al.
Cancer Investigation|February 6, 2026
Predictive and Prognostic Value of p16 in Head and Neck Squamous Cell Carcinoma Patients Treated with Molecular Targeted Agents or Immune Checkpoint Inhibitors: Subgroup Analysis of the TRIUMPH StudyHyerim Ha, Sang Hoon Chun, Yun-Gyoo Lee, et al.
Cancers|July 9, 2020
Prognostic Value of <i>CD200R1</i> mRNA Expression in Head and Neck Squamous Cell CarcinomaHyun Chang, Yun-Gyoo Lee, Yoon Ho Ko, et al.
JTO Clinical and Research Reports|December 2, 2024
Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18Dae-Ho Choi, Miso Kim, Young Saing Kim, et al.
BMC Cancer|February 23, 2024
Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06)Sung Hee Lim, Keun-Wook Lee, Jae-Joon Kim, et al.
Translational Lung Cancer Research|April 15, 2026
Molecular and clinical disparity of <i>EGFR</i>-mutant non-small cell lung cancer (NSCLC) based on histopathological stage and <i>EGFR</i> molecular subtypesDayoung Yoon, Ji Won Lee, Byoung Chul Cho, et al.
Cancer Research and Treatment|May 21, 2021
Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic AlterationsYoon Ji Choi, Jung Yoon Choi, Ju Won Kim, et al.
Journal of Gastric Cancer|January 17, 2025
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline)In-Ho Kim, Seung Joo Kang, Wonyoung Choi, et al.
Pageof 4